So, inhibition of CaMKII by KN‐93, which was a widely used inhibitor of CaMKII, impaired myocardial angiogenesis and aggravated cardiac remodelling and HF via inhibiting NOX2/mtROS/p‐VEGFR2 and STAT3 pathways. This evidence concerns the gene CYBB and hydrops fetalis.